Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 465

1.

Active vitamin D and vitamin D analogs stimulate fibroblast growth factor 23 production in osteocyte-like cells via the vitamin D receptor.

Yashiro M, Ohya M, Mima T, Nakashima Y, Kawakami K, Yamamoto S, Kobayashi S, Yano T, Tanaka Y, Sonou T, Tatsuta K, Negi S, Shigematsu T.

J Pharm Biomed Anal. 2020 Jan 31;182:113139. doi: 10.1016/j.jpba.2020.113139. [Epub ahead of print]

PMID:
32045827
2.

Direct tumor embolism presenting as an acute ischemic stroke.

Lemus HN, Lu C, Shoirah H, Shigematsu T, Liang J, Van Denakker T, Boniece I, Skliut M.

Neurol Clin Pract. 2019 Dec;9(6):490-493. doi: 10.1212/CPJ.0000000000000682. No abstract available.

PMID:
32042487
3.

Correlation between haemoglobin level and type of erythropoiesis-stimulating agent at initiation of haemodialysis.

Higashiura M, Ohya M, Tanaka Y, Yano T, Yamamoto S, Mima T, Negi S, Shigematsu T.

Int J Clin Pharm. 2020 Feb 6. doi: 10.1007/s11096-020-00983-9. [Epub ahead of print]

PMID:
32026357
4.

Influence of dialysate Ca concentrations on the therapeutic effects of etelcalcetide with concomitant drugs in patients with secondary hyperparathyroidism.

Shigematsu T, Fukagawa M, Yokoyama K, Akiba T, Fujii A, Shinoda A, Akizawa T.

Nephrology (Carlton). 2019 Nov 25. doi: 10.1111/nep.13682. [Epub ahead of print]

PMID:
31765028
5.

Clinical significance of corrected relative flow reserve derived from 13N-ammonia positron emission tomography combined with coronary computed tomography angiography.

Kawaguchi N, Okayama H, Kido T, Fukuyama N, Shigematsu T, Kawamura G, Hiasa G, Kazatani Y, Inoue T, Miki H, Miyagawa M, Mochizuki T.

J Nucl Cardiol. 2019 Nov 11. doi: 10.1007/s12350-019-01931-5. [Epub ahead of print]

PMID:
31713117
6.

Management of a laryngeal venous malformation with Nd:YAG laser and bleomycin sclerotherapy.

Manna S, Meyer A, Shigematsu T, Berenstein A, Courey M.

Laryngoscope. 2019 Nov 11. doi: 10.1002/lary.28392. [Epub ahead of print]

PMID:
31710699
7.

Comparison of four commercial immunoassays used in measuring the concentration of tacrolimus in blood, and their cross-reactivity to its metabolites.

Shigematsu T, Suetsugu K, Yamamoto N, Tsuchiya Y, Masuda S.

Ther Drug Monit. 2019 Sep 14. doi: 10.1097/FTD.0000000000000696. [Epub ahead of print]

PMID:
31568181
8.

Urinary Human Epididymis Secretory Protein 4 as a Useful Biomarker for Subclinical Acute Rejection Three Months after Kidney Transplantation.

Tajima S, Fu R, Shigematsu T, Noguchi H, Kaku K, Tsuchimoto A, Okabe Y, Masuda S.

Int J Mol Sci. 2019 Sep 22;20(19). pii: E4699. doi: 10.3390/ijms20194699.

9.

An Analysis of Medication Adherence and Patient Preference in Long-term Stable Maintenance Hemodialysis Patients in Japan.

Ohya M, Iwashita Y, Kunimoto S, Yamamoto S, Mima T, Negi S, Shigematsu T.

Intern Med. 2019 Sep 15;58(18):2595-2603. doi: 10.2169/internalmedicine.2676-19. Epub 2019 Jun 7.

10.

Effect of hyperuricemia and treatment for hyperuricemia in Japanese hemodialysis patients: A cohort study.

Sugano N, Maruyama Y, Kidoguchi S, Ohno I, Wada A, Shigematsu T, Masakane I, Yokoo T.

PLoS One. 2019 Jun 6;14(6):e0217859. doi: 10.1371/journal.pone.0217859. eCollection 2019.

11.

Impact of CYP3A5, POR, and CYP2C19 Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplantation.

Suetsugu K, Mori Y, Yamamoto N, Shigematsu T, Miyamoto T, Egashira N, Akashi K, Masuda S.

Int J Mol Sci. 2019 May 15;20(10). pii: E2413. doi: 10.3390/ijms20102413.

12.

Endovascular treatment for large vessel occlusion stroke in patients with ventricular assist devices.

Kadono Y, Nakamura H, Saito S, Nishida T, Takagaki M, Shigematsu T, Asai K, Murakami T, Todo K, Fujinaka T, Sakaguchi M, Toda K, Sawa Y, Kishima H.

J Neurointerv Surg. 2019 Dec;11(12):1205-1209. doi: 10.1136/neurintsurg-2018-014645. Epub 2019 May 2.

PMID:
31048456
13.

Predilution On-Line Hemodiafiltration Improves Albumin Redox in Maintenance Hemodialysis Patients.

Shigematsu T, Kuragano T, Kamimura T, Kawada S, Imamura R, Nishian Y, Miyamoto M, Miyamoto T, Nakanishi T.

Blood Purif. 2019;47 Suppl 2:19-24. doi: 10.1159/000496631. Epub 2019 Apr 3.

PMID:
30943515
14.

Bicelle-to-Vesicle Transition of a Binary Phospholipid Mixture Guided by Controlled Local Lipid Compositions: A Molecular Dynamics Simulation Study.

Koshiyama K, Taneo M, Shigematsu T, Wada S.

J Phys Chem B. 2019 Apr 11;123(14):3118-3123. doi: 10.1021/acs.jpcb.8b10682. Epub 2019 Mar 28.

PMID:
30888822
15.

A study of second-line irinotecan plus cisplatin vs. irinotecan alone in platinum-naïve patients with early relapse of gastric cancer refractory to adjuvant S-1 monotherapy: exploratory subgroup analysis of the randomized phase III TRICS trial.

Nishikawa K, Murotani K, Fujitani K, Inagaki H, Akamaru Y, Tokunaga S, Takagi M, Tamura S, Sugimoto N, Shigematsu T, Yoshikawa T, Ishiguro T, Nakamura M, Hasegawa H, Morita S, Miyashita Y, Tsuburaya A, Sakamoto J, Tsujinaka T.

Cancer Chemother Pharmacol. 2019 May;83(5):867-874. doi: 10.1007/s00280-019-03802-9. Epub 2019 Feb 26.

PMID:
30806758
16.

Novel bisphosphonate compound FYB-931 preferentially inhibits aortic calcification in vitamin D3-treated rats.

Ishida K, Ashizawa N, Matsumoto K, Kobashi S, Kurita N, Shigematsu T, Iwanaga T.

J Bone Miner Metab. 2019 Sep;37(5):796-804. doi: 10.1007/s00774-019-00987-0. Epub 2019 Feb 2.

PMID:
30712064
17.

[The prevention and treatment of vascular calcification.]

Kawakami K, Ohya M, Shigematsu T.

Clin Calcium. 2019;29(2):231-236. doi: 10.20837/4201902231. Japanese.

PMID:
30679405
18.

Commentary: Vein of Galen Malformations: The Texas Children's Hospital Experience in the Modern Endovascular Era.

Berenstein A, Shigematsu T.

Oper Neurosurg (Hagerstown). 2019 Sep 1;17(3):E98-E99. doi: 10.1093/ons/opy374. No abstract available.

PMID:
30551167
19.

Efficacy and safety of once-monthly risedronate in osteoporosis subjects with mild-to-moderate chronic kidney disease: a post hoc subgroup analysis of a phase III trial in Japan.

Sugimoto T, Inoue D, Maehara M, Oikawa I, Shigematsu T, Nishizawa Y.

J Bone Miner Metab. 2019 Jul;37(4):730-740. doi: 10.1007/s00774-018-0977-1. Epub 2018 Dec 6.

PMID:
30523414
20.

Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial.

J-DAVID Investigators, Shoji T, Inaba M, Fukagawa M, Ando R, Emoto M, Fujii H, Fujimori A, Fukui M, Hase H, Hashimoto T, Hirakata H, Honda H, Hosoya T, Ikari Y, Inaguma D, Inoue T, Isaka Y, Iseki K, Ishimura E, Itami N, Ito C, Kakuta T, Kawai T, Kawanishi H, Kobayashi S, Kumagai J, Maekawa K, Masakane I, Minakuchi J, Mitsuiki K, Mizuguchi T, Morimoto S, Murohara T, Nakatani T, Negi S, Nishi S, Nishikawa M, Ogawa T, Ohta K, Ohtake T, Okamura M, Okuno S, Shigematsu T, Sugimoto T, Suzuki M, Tahara H, Takemoto Y, Tanaka K, Tominaga Y, Tsubakihara Y, Tsujimoto Y, Tsuruya K, Ueda S, Watanabe Y, Yamagata K, Yamakawa T, Yano S, Yokoyama K, Yorioka N, Yoshiyama M, Nishizawa Y.

JAMA. 2018 Dec 11;320(22):2325-2334. doi: 10.1001/jama.2018.17749.

21.

Effects of the Intravenous Calcimimetic Etelcalcetide on Bone Turnover and Serum Fibroblast Growth Factor 23: Post Hoc Analysis of an Open-label Study.

Shigematsu T, Fukagawa M, Yokoyama K, Akiba T, Fujii A, Odani M, Akizawa T.

Clin Ther. 2018 Dec;40(12):2099-2111. doi: 10.1016/j.clinthera.2018.10.016. Epub 2018 Nov 23.

22.

Pharmacokinetics of evocalcet in secondary hyperparathyroidism patients receiving hemodialysis: first-in-patient clinical trial in Japan.

Shigematsu T, Shimazaki R, Fukagawa M, Akizawa T.

Clin Pharmacol. 2018 Sep 11;10:101-111. doi: 10.2147/CPAA.S171044. eCollection 2018.

23.

A Case of Chronic Calcium Oxalate Nephropathy due to Short Bowel Syndrome and Cholecystectomy.

Hashimoto S, Yamamoto R, Maoka T, Fukasawa Y, Koike T, Shigematsu T.

Case Rep Nephrol Dial. 2018 Aug 10;8(2):147-154. doi: 10.1159/000491630. eCollection 2018 May-Aug.

24.

Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients.

Shigematsu T, Shimazaki R, Fukagawa M, Akizawa T; Evocalcet Study Group.

Clin Exp Nephrol. 2019 Feb;23(2):258-267. doi: 10.1007/s10157-018-1635-6. Epub 2018 Aug 29.

25.

The Japanese Clinical Practice Guideline for acute kidney injury 2016.

Doi K, Nishida O, Shigematsu T, Sadahiro T, Itami N, Iseki K, Yuzawa Y, Okada H, Koya D, Kiyomoto H, Shibagaki Y, Matsuda K, Kato A, Hayashi T, Ogawa T, Tsukamoto T, Noiri E, Negi S, Kamei K, Kitayama H, Kashihara N, Moriyama T, Terada Y; Japanese Clinical Practice Guideline for Acute Kidney Injury 2016 Committee.

J Intensive Care. 2018 Aug 13;6:48. doi: 10.1186/s40560-018-0308-6. eCollection 2018.

26.

Association of Circulatory Iron Deficiency With an Enlarged Heart in Patients With End-Stage Kidney Disease.

Hayashi T, Tanaka Y, Iwasaki M, Hase H, Yamamoto H, Komatsu Y, Ando R, Ikeda M, Inaguma D, Sakaguchi T, Shinoda T, Koiwa F, Negi S, Yamaka T, Shigematsu T, Joki N.

J Ren Nutr. 2019 Jan;29(1):39-47. doi: 10.1053/j.jrn.2018.05.004. Epub 2018 Aug 7.

PMID:
30097326
27.

Novel aspiration catheter design for acute stroke thrombectomy.

Long TD, Kallmes DF, Hanel R, Shigematsu T, Halaszyn AM, Wolter J, Berenstein A.

J Neurointerv Surg. 2019 Feb;11(2):190-195. doi: 10.1136/neurintsurg-2017-013702. Epub 2018 Jul 30.

28.

Intravenous Maxacalcitol Therapy Correlates with Serum Fibroblast Growth Factor 23 Levels in Hemodialysis Patients Independent of Serum Phosphate or Calcium Levels.

Ohya M, Yashiro M, Sonou T, Okuda K, Tatsuta K, Mima T, Tone Y, Negi S, Saika Y, Shigematsu T.

Contrib Nephrol. 2018;196:44-51. doi: 10.1159/000485696. Epub 2018 Jul 24.

PMID:
30041203
29.

The Japanese clinical practice guideline for acute kidney injury 2016.

Doi K, Nishida O, Shigematsu T, Sadahiro T, Itami N, Iseki K, Yuzawa Y, Okada H, Koya D, Kiyomoto H, Shibagaki Y, Matsuda K, Kato A, Hayashi T, Ogawa T, Tsukamoto T, Noiri E, Negi S, Kamei K, Kitayama H, Kashihara N, Moriyama T, Terada Y; Japanese Clinical Practice Guideline for Acute Kidney Injury 2016 Committee.

Clin Exp Nephrol. 2018 Oct;22(5):985-1045. doi: 10.1007/s10157-018-1600-4. Review.

30.

A Survey of Drug Burden in Patients Undergoing Maintenance Hemodialysis in Japan.

Iwashita Y, Ohya M, Kunimoto S, Iwashita Y, Mima T, Negi S, Shigematsu T.

Intern Med. 2018 Oct 15;57(20):2937-2944. doi: 10.2169/internalmedicine.0108-17. Epub 2018 May 18.

31.

Dietary Changes Involving Bifidobacterium longum and Other Nutrients Delays Chronic Kidney Disease Progression.

Iwashita Y, Ohya M, Yashiro M, Sonou T, Kawakami K, Nakashima Y, Yano T, Iwashita Y, Mima T, Negi S, Kubo K, Tomoda K, Odamaki T, Shigematsu T.

Am J Nephrol. 2018;47(5):325-332. doi: 10.1159/000488947. Epub 2018 May 18.

PMID:
29779028
32.

Acute kidney injury: Epidemiology, outcomes, complications, and therapeutic strategies.

Negi S, Koreeda D, Kobayashi S, Yano T, Tatsuta K, Mima T, Shigematsu T, Ohya M.

Semin Dial. 2018 Sep;31(5):519-527. doi: 10.1111/sdi.12705. Epub 2018 May 8. Review.

PMID:
29738093
33.

Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.

Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Yoshio T, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.

Clin Exp Nephrol. 2018 Dec;22(6):1266-1280. doi: 10.1007/s10157-018-1579-x. Epub 2018 Apr 20.

PMID:
29679356
34.

Bleomycin sclerotherapy for eyelid venous malformations as an alternative to surgery or laser therapy.

Shigematsu T, Sorscher M, Dier EC, Berenstein A.

J Neurointerv Surg. 2019 Jan;11(1):57-61. doi: 10.1136/neurintsurg-2018-013813. Epub 2018 Apr 19.

PMID:
29674482
35.

FGF23 modulates the effects of erythropoietin on gene expression in renal epithelial cells.

Yashiro M, Ohya M, Mima T, Ueda Y, Nakashima Y, Kawakami K, Ishizawa Y, Yamamoto S, Kobayashi S, Yano T, Tanaka Y, Okuda K, Sonou T, Shoshihara T, Iwashita Y, Iwashita Y, Tatsuta K, Matoba R, Negi S, Shigematsu T.

Int J Nephrol Renovasc Dis. 2018 Apr 4;11:125-136. doi: 10.2147/IJNRD.S158422. eCollection 2018.

36.

Severe refractory infection due to renocolic fistula in a patient with a giant kidney and ADPKD undergoing long-term hemodialysis.

Iwashita Y, Negi S, Iwashita Y, Higashiura M, Shigi Y, Yamanaka S, Ohya M, Mima T, Shigematsu T.

CEN Case Rep. 2018 May;7(1):174-177. doi: 10.1007/s13730-018-0321-6. Epub 2018 Mar 14.

37.

Stretch-Induced Interdigitation of a Phospholipid/Cholesterol Bilayer.

Shigematsu T, Koshiyama K, Wada S.

J Phys Chem B. 2018 Mar 8;122(9):2556-2563. doi: 10.1021/acs.jpcb.7b10633. Epub 2018 Feb 26.

PMID:
29419298
38.

Beneficial effects of adaptive servo-ventilation therapy on readmission and medical costs in patients with chronic heart failure.

Hiasa G, Okayama H, Hosokawa S, Kosaki T, Kawamura G, Shigematsu T, Takahashi T, Kawada Y, Yamada T, Matsuoka H, Saito M, Sumimoto T, Kazatani Y.

Heart Vessels. 2018 Aug;33(8):859-865. doi: 10.1007/s00380-018-1124-6. Epub 2018 Jan 22.

PMID:
29357095
39.

Ultrasonography to Measure Swallowing Muscle Mass and Quality in Older Patients With Sarcopenic Dysphagia.

Ogawa N, Mori T, Fujishima I, Wakabayashi H, Itoda M, Kunieda K, Shigematsu T, Nishioka S, Tohara H, Yamada M, Ogawa S.

J Am Med Dir Assoc. 2018 Jun;19(6):516-522. doi: 10.1016/j.jamda.2017.11.007. Epub 2017 Dec 26.

PMID:
29287693
40.

Isolated Left Atrial Infective Mural Endocarditis.

Hosokawa S, Okayama H, Hiasa G, Kawamura G, Shigematsu T, Takahashi T, Kawada Y, Yamada T, Matsuoka H, Kazatani Y.

Intern Med. 2018 Apr 1;57(7):957-960. doi: 10.2169/internalmedicine.9559-17. Epub 2017 Dec 8. Review.

41.

A Single- and Multiple-Dose, Multicenter Study of Etelcalcetide in Japanese Hemodialysis Patients With Secondary Hyperparathyroidism.

Yokoyama K, Fukagawa M, Shigematsu T, Akiba T, Fujii A, Yamauchi A, Odani M, Akizawa T; ONO-5163 Study Group.

Kidney Int Rep. 2017 Feb 20;2(4):634-644. doi: 10.1016/j.ekir.2017.01.016. eCollection 2017 Jul.

42.

Clinical Usefulness of Coronary Flow Reserve Ratio for the Detection of Significant Coronary Artery Disease on 13N-Ammonia Positron Emission Tomography.

Kawaguchi N, Okayama H, Kawamura G, Shigematsu T, Takahashi T, Kawada Y, Hiasa G, Yamada T, Matsuoka H, Kazatani Y, Miyagawa M, Mochizuki T.

Circ J. 2018 Jan 25;82(2):486-493. doi: 10.1253/circj.CJ-17-0745. Epub 2017 Sep 26.

43.

Appropriate nutritional management in patients with impaired mastication and those with mild dysphagia: a multicenter study of the usefulness of novel foods processed and softened by enzymes.

Higashiguchi T, Ito A, Nishiyama H, Shigematsu T, Ishikawa A, Kato H, Iijima S, Kikuchi N.

Asia Pac J Clin Nutr. 2017;26(6):1007-1015. doi: 10.6133/apjcn.122016.01.

44.

Favorable effects of early tolvaptan administration in very elderly patients after repeat hospitalizations for acute decompensated heart failure.

Kinoshita M, Okayama H, Kosaki T, Hosokawa S, Kawamura G, Shigematsu T, Takahashi T, Kawada Y, Hiasa G, Yamada T, Matsuoka H, Kazatani Y.

Heart Vessels. 2018 Feb;33(2):163-169. doi: 10.1007/s00380-017-1048-6. Epub 2017 Sep 9.

PMID:
28889231
45.

Long-term effects of etelcalcetide as intravenous calcimimetic therapy in hemodialysis patients with secondary hyperparathyroidism.

Shigematsu T, Fukagawa M, Yokoyama K, Akiba T, Fujii A, Odani M, Akizawa T; ONO-5163 Study Group.

Clin Exp Nephrol. 2018 Apr;22(2):426-436. doi: 10.1007/s10157-017-1442-5. Epub 2017 Aug 23.

PMID:
28836058
46.

Radiation-Induced Cardiomyopathy Incidentally Detected on Oncology 18F-Fluorodeoxyglucose Positron Emission Tomography.

Kawamura G, Okayama H, Kawaguchi N, Hosokawa S, Kosaki T, Shigematsu T, Takahashi T, Kawada Y, Hiasa G, Yamada T, Matsuoka H, Kazatani Y.

Circ J. 2018 Mar 23;82(4):1210-1212. doi: 10.1253/circj.CJ-17-0466. Epub 2017 Aug 18. No abstract available.

47.

A 12-week dose-escalating study of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese hemodialysis patients
.

Yokoyama K, Fukagawa M, Shigematsu T, Akiba T, Fujii A, Odani M, Akizawa T.

Clin Nephrol. 2017 Aug;88(2):68-78. doi: 10.5414/CN108974.

PMID:
28671062
48.

Comparative analysis on inactivation kinetics of between piezotolerant and piezosensitive mutant strains of Saccharomyces cerevisiae under combinations of high hydrostatic pressure and temperature.

Nomura K, Kuwabara Y, Kuwabara W, Takahashi H, Nakajima K, Hayashi M, Iguchi A, Shigematsu T.

Biophys Chem. 2017 Dec;231:87-94. doi: 10.1016/j.bpc.2017.05.014. Epub 2017 May 24.

PMID:
28578998
49.

Multicentre cross-sectional study for bone-articular lesions associated with dialysis related amyloidosis in Japan.

Nishi S, Hoshino J, Yamamoto S, Goto S, Fujii H, Ubara Y, Motomiya Y, Morita H, Takaichi K, Yamagata K, Shigematsu T, Ueda M, Ando Y.

Nephrology (Carlton). 2018 Jul;23(7):640-645. doi: 10.1111/nep.13077.

PMID:
28556529
50.

Effect of high pressure on the saccharification of starch in the tuberous root of sweet potato (Ipomoea batatas).

Shigematsu T, Furukawa N, Takaoka R, Hayashi M, Sasao S, Ueno S, Nakajima K, Kido M, Nomura K, Iguchi A.

Biophys Chem. 2017 Dec;231:105-110. doi: 10.1016/j.bpc.2017.04.012. Epub 2017 May 1.

PMID:
28506613

Supplemental Content

Loading ...
Support Center